These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15505297)

  • 1. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance.
    Giorgio A; Ferraioli G; Tarantino L; de Stefano G; Scala V; Scarano F; Coppola C; Del Viscovo L
    AJR Am J Roentgenol; 2004 Nov; 183(5):1319-26. PubMed ID: 15505297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
    Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
    Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity rates in characterizing hepatocellular carcinomas.
    Caturelli E; Ghittoni G; Roselli P; Anti M
    AJR Am J Roentgenol; 2005 Oct; 185(4):1079-80; author reply 1080-1. PubMed ID: 16177438
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography.
    Gaiani S; Celli N; Piscaglia F; Cecilioni L; Losinno F; Giangregorio F; Mancini M; Pini P; Fornari F; Bolondi L
    J Hepatol; 2004 Sep; 41(3):421-6. PubMed ID: 15336445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation.
    Takayasu K; Furukawa H; Wakao F; Muramatsu Y; Abe H; Terauchi T; Winter TC; Sakamoto M; Hirohashi S
    AJR Am J Roentgenol; 1995 Apr; 164(4):885-90. PubMed ID: 7726041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?
    Ricci P; Cantisani V; Drudi F; Pagliara E; Bezzi M; Meloni F; Calliada F; Erturk SM; D'Andrea V; D'Ambrosio U; Passariello R
    Ultraschall Med; 2009 Jun; 30(3):252-8. PubMed ID: 19280552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.
    Hayashi M; Matsui O; Ueda K; Kawamori Y; Kadoya M; Yoshikawa J; Gabata T; Takashima T; Nonomura A; Nakanuma Y
    AJR Am J Roentgenol; 1999 Apr; 172(4):969-76. PubMed ID: 10587130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT.
    Lee HM; Lu DS; Krasny RM; Busuttil R; Kadell B; Lucas J
    AJR Am J Roentgenol; 1997 Jul; 169(1):125-30. PubMed ID: 9207511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT detection of hepatocellular carcinoma in advanced liver cirrhosis: correlation of helical CT and explanted liver.
    Lim JH; Kim MJ; Chiang LW; Lim HK; Park CK; Paik SW; Koh KC; Joh JW
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):201-8. PubMed ID: 12499806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients.
    Bennett GL; Krinsky GA; Abitbol RJ; Kim SY; Theise ND; Teperman LW
    AJR Am J Roentgenol; 2002 Jul; 179(1):75-80. PubMed ID: 12076908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
    Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
    AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
    Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
    Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI.
    Meloni MF; Bertolotto M; Alberzoni C; Lazzaroni S; Filice C; Livraghi T; Ferraioli G
    AJR Am J Roentgenol; 2008 Oct; 191(4):1233-8. PubMed ID: 18806170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma.
    Giorgio A; Tarantino L; de Stefano G; Scala V; Liorre G; Scarano F; Perrotta A; Farella N; Aloisio V; Mariniello N; Coppola C; Francica G; Ferraioli G
    AJR Am J Roentgenol; 2003 Aug; 181(2):479-84. PubMed ID: 12876030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
    Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
    AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
    Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
    AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Kumano S; Okada A; Sugiura T; Nakamura H
    AJR Am J Roentgenol; 2003 Feb; 180(2):455-60. PubMed ID: 12540451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.